25.72 USD
-0.34 (-1.3%)
At close: Jan 30, 2026
25 USD
-0.72 (-2.8%)
After Hours: 1/30/2026, 8:11:39 PM
OLMA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. While OLMA seems to be doing ok healthwise, there are quite some concerns on its profitability. OLMA has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year OLMA has reported negative net income.
- In the past year OLMA has reported a negative cash flow from operations.
- In the past 5 years OLMA always reported negative net income.
- OLMA had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- OLMA has a Return On Assets (-42.55%) which is in line with its industry peers.
- With a decent Return On Equity value of -48.77%, OLMA is doing good in the industry, outperforming 67.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.55% | ||
| ROE | -48.77% | ||
| ROIC | N/A |
ROA(3y)-37.4%
ROA(5y)-28.65%
ROE(3y)-40.93%
ROE(5y)-30.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for OLMA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- OLMA has more shares outstanding than it did 1 year ago.
- OLMA has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for OLMA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- OLMA has an Altman-Z score of 24.25. This indicates that OLMA is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of OLMA (24.25) is better than 91.43% of its industry peers.
- OLMA has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- OLMA has a Debt to Equity ratio (0.01) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 24.25 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 8.03 indicates that OLMA has no problem at all paying its short term obligations.
- With a decent Current ratio value of 8.03, OLMA is doing good in the industry, outperforming 74.29% of the companies in the same industry.
- OLMA has a Quick Ratio of 8.03. This indicates that OLMA is financially healthy and has no problem in meeting its short term obligations.
- OLMA has a Quick ratio of 8.03. This is in the better half of the industry: OLMA outperforms 74.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 8.03 | ||
| Quick Ratio | 8.03 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 14.61% over the past year.
EPS 1Y (TTM)14.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- OLMA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.79% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y12.97%
EPS Next 2Y-4.4%
EPS Next 3Y-7.47%
EPS Next 5Y0.79%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for OLMA. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OLMA. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- OLMA's earnings are expected to decrease with -7.47% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.4%
EPS Next 3Y-7.47%
5. Dividend
5.1 Amount
- No dividends for OLMA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
OLEMA PHARMACEUTICALS INC / OLMA FAQ
What is the ChartMill fundamental rating of OLEMA PHARMACEUTICALS INC (OLMA) stock?
ChartMill assigns a fundamental rating of 2 / 10 to OLMA.
What is the valuation status of OLEMA PHARMACEUTICALS INC (OLMA) stock?
ChartMill assigns a valuation rating of 0 / 10 to OLEMA PHARMACEUTICALS INC (OLMA). This can be considered as Overvalued.
How profitable is OLEMA PHARMACEUTICALS INC (OLMA) stock?
OLEMA PHARMACEUTICALS INC (OLMA) has a profitability rating of 1 / 10.
What is the earnings growth outlook for OLEMA PHARMACEUTICALS INC?
The Earnings per Share (EPS) of OLEMA PHARMACEUTICALS INC (OLMA) is expected to grow by 12.97% in the next year.